Posts

Showing posts from December, 2020

(10p) Codeine as example how product information of medicines continue to change

Image
This article is a follow-up of my previous article to illustrate how the product information of medication is never final but pharmaceutical companies continue to update the information to be sure healthcare professionals and patients can trust that the information is up-to-date and medications are safe to use.  When companies want to make changes or government medicine agencies tell them to do so, companies must submit dossiers to these agencies and pay for the assessment of the suggested changes and after their approval, the updated product information will be published on the website of medicine agencies but also printed in the leaflet that is enclosed in the packaging of the medication. And yes, civil servants working at those agencies declare each year that they have no conflicts of interest and thus are independent from the companies to work in the interest of society.   Codeine can be taken as example of what happens after medications receive their authorisation as the public

(10o) Pharmaceutical companies need to earn money to improve their products

Image
The anti-science and anti-companies or, more general anti-establishment movements continue to grow and not only in the USA when you see on social media the growing numbers of conspiracy theories that question e.g. pharmaceutical companies but even doctors and nurses . Yes, it is correct that some (people working in) pharmaceutical companies think more about profits than about helping people, or at least that impression we have. But the majority in those companies are people who want to help people to reach an old age in good health.  Pharmaceutical companies as friends People claim that pharmaceutical companies should be more open and even question whether patents should exist while patents earn companies money that they invested in past research but also will invest in future research while they have to pay their legal obligations and their employees and investors ( this article  projects what pharmaceutical companies may earn from the Covid-19 vaccines while I am not naive  as big